Browsing by author "Bernal del Castillo, Teresa"

Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: Results of a prospective, multicenter, phase II clinical trial

Briones, Javier; Novelli, Silvana; García-Marco, José A.; Tomás, José F.; Bernal del Castillo, Teresa

; Grande, Carlos; Canales, Miguel A.; Torres, Antonio; Moraleda, José M.; Panizo, C.; Jarque, Isidro; Palmero, Francisca; Hernández, Miguel; González-Barca, Eva; López, Dulce; Caballero, Dolores (2014)

Blood, sweat, and teARDS

Bernal del Castillo, Teresa

; Muñiz Albaiceta, Guillermo

(2016)

Calidad de vida en pacientes afectos de síndromes mielodisplasicos

Bernal del Castillo, Teresa

(1998)

Clinical and biological characterization of low risk MDS patients according to ring sideroblasts (RS). Comparison between the 3 subgroups in WHO2017 classification. Study from the Spanish MDS registry

López Cadenas, Félix; Bernal del Castillo, Teresa

; Sanz, Guillermo (2021)

Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: the authors' reply

Bernal del Castillo, Teresa

; Martínez Camblor, Pablo

; Sánchez García, Joaquín; Sanz, Guillermo (2016)

Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: Results from the Spanish Registry

Bernal del Castillo, Teresa

; Martínez Camblor, Pablo

; Sánchez García, Joaquín; Paz, Raquel de; Luño Fernández, Elisa

; Nomdedeu, Benet; Ardanaz, María Teresa; Pedro, Carme; Amigo, M. L.; Xicoy, Blanca (Nature Publishing Group, 2015)

Effects of azacitidine on matrix metalloproteinase-9 in acute myeloid leukemia and myelodysplasia

Bernal del Castillo, Teresa

; Moncada Pazos, Ángela

; Soria Valles, Clara

; Gutiérrez Fernández, Ana Yolanda

(2013)

Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group

Ribera, Josep María; García, Olga; Oriol, Albert; Bernal del Castillo, Teresa

(2016)

Genomic data improves prognostic stratification in adult t-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials

González Gil, Celia; Morgade, Mireia; Fuster Tormo, Francisco; Bernal del Castillo, Teresa

(2021)

Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors

González Urdinguio, Rocío

; Fernández Fernández, Agustín

; Moncada Pazos, Ángela

; Huidobro Fernández, Covadonga

; Rodríguez López, Ramón María

; Ferrero Rodríguez, Cecilia

; Martínez Camblor, Pablo

; Obaya González, Álvaro Jesús

; Bernal del Castillo, Teresa

; Parra Blanco, Adolfo

; Rodrigo Sáez, Luis Ricardo

; Santacana, María; Matías Guíu, Xavier; Soldevilla Navarro, Beatriz; Domínguez, Gemma; Bonilla, Félix; Cal Miguel, Santiago Jesús

; López Otín, Carlos

; Fernández Fraga, Mario

(2013)

The impact of antimicrobial prophylaxis in morbidity and infections during azacitidine treatment

Lorenzana, Natalia; Francisca Ávila, Laura; Alonso Álvarez, Sara; Colado Varela, Enrique; Bernal del Castillo, Teresa

(2017)

Impact of Initial Ventilatory Strategy in Hematological Patients With Acute Respiratory Failure: A Systematic Review and Meta-Analysis

Amado Rodríguez, Laura

; Bernal del Castillo, Teresa

; López Alonso, Inés

; Blázquez Prieto, Jorge

; García Prieto, Emilio

; Muñiz Albaiceta, Guillermo

(2016)

Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy

Kelleher, N.; Gallardo, D.; González Campos, J.; Bernal del Castillo, Teresa

; Pethema Group; Spanish Society of Hematology (2016)

Indication of palliative care in elderly patients with acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with patients with solid tumors

Morais Bras, L. R.; Bernal Cueto, S.; Díaz Valdés, M.; Pola Díaz, A.; Castañón Fernández, C.; Alonso Álvarez, Sara; Colado Varela, Enrique; Bernal del Castillo, Teresa

(2018)

Indication of palliative care in patients with non-hodgkin's lymphoma: comparison with solid neoplasms

Morais Bras, L. R.; Fernández de Dios, L.; Fernández Morán, E.; García Martínez, S.; Castañón Fernández, C.; Alonso Álvarez, Sara; Colado Varela, Enrique; Bernal del Castillo, Teresa

(2018)

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

Dombret, H.; Seymour, John F.; Butrym, Aleksandra; Bernal del Castillo, Teresa

(2015)

Mapping the genetic features of T-ALL cases through simplified NGS approach

García Aznar, José María; Alonso, Sara; Uña Iglesias, David de; López de Ugarriza, Paula; Álvarez López, Carmen

; Balbín Felechosa, Milagros

; Bernal del Castillo, Teresa

(2022)

Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis

Rodríguez Folgueras, Alicia

; Martín de Lara, Fernando; Martín Pendás, José Alberto

; Garabaya Fernández, Cecilia

; Rodríguez, Francisco; Astudillo González, María Aurora

; Bernal del Castillo, Teresa

; Cabanillas Farpón, Rubén

; López Otín, Carlos

; Velasco Cotarelo, María Gloria

(2008)

Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study

Pleyer, Lisa; Leisch, Michael; Kourakli, Alexandra; Bernal del Castillo, Teresa

(2021)

Overall Survival in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) with > 30% Bone Marrow Blasts Treated with Azacitidine By Cytogenetic Risk Status: Results of the AZA-AML-001 Study

Doehner, Hartmut; Seymour, John F.; Butrym, Aleksandra; Bernal del Castillo, Teresa

(2014)

Browsing by author "Bernal del Castillo, Teresa"

Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: Results of a prospective, multicenter, phase II clinical trial ﻿

Blood, sweat, and teARDS ﻿

Calidad de vida en pacientes afectos de síndromes mielodisplasicos ﻿

Clinical and biological characterization of low risk MDS patients according to ring sideroblasts (RS). Comparison between the 3 subgroups in WHO2017 classification. Study from the Spanish MDS registry ﻿

Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: the authors' reply ﻿

Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: Results from the Spanish Registry ﻿

Effects of azacitidine on matrix metalloproteinase-9 in acute myeloid leukemia and myelodysplasia ﻿

Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group ﻿

Genomic data improves prognostic stratification in adult t-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials ﻿

Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors ﻿

The impact of antimicrobial prophylaxis in morbidity and infections during azacitidine treatment ﻿

Impact of Initial Ventilatory Strategy in Hematological Patients With Acute Respiratory Failure: A Systematic Review and Meta-Analysis ﻿

Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy ﻿

Indication of palliative care in elderly patients with acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with patients with solid tumors ﻿

Indication of palliative care in patients with non-hodgkin's lymphoma: comparison with solid neoplasms ﻿

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts ﻿

Mapping the genetic features of T-ALL cases through simplified NGS approach ﻿

Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis ﻿

Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study ﻿

Overall Survival in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) with > 30% Bone Marrow Blasts Treated with Azacitidine By Cytogenetic Risk Status: Results of the AZA-AML-001 Study ﻿

Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: Results of a prospective, multicenter, phase II clinical trial

Blood, sweat, and teARDS

Calidad de vida en pacientes afectos de síndromes mielodisplasicos

Clinical and biological characterization of low risk MDS patients according to ring sideroblasts (RS). Comparison between the 3 subgroups in WHO2017 classification. Study from the Spanish MDS registry

Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: the authors' reply

Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: Results from the Spanish Registry

Effects of azacitidine on matrix metalloproteinase-9 in acute myeloid leukemia and myelodysplasia

Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group

Genomic data improves prognostic stratification in adult t-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials

Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors

The impact of antimicrobial prophylaxis in morbidity and infections during azacitidine treatment

Impact of Initial Ventilatory Strategy in Hematological Patients With Acute Respiratory Failure: A Systematic Review and Meta-Analysis

Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy

Indication of palliative care in elderly patients with acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with patients with solid tumors

Indication of palliative care in patients with non-hodgkin's lymphoma: comparison with solid neoplasms

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

Mapping the genetic features of T-ALL cases through simplified NGS approach

Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis

Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study

Overall Survival in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) with > 30% Bone Marrow Blasts Treated with Azacitidine By Cytogenetic Risk Status: Results of the AZA-AML-001 Study